Redeye states that while Q2 was soft, it was due to a timing effect implying that Q3 will be strong. Sivers maintains its 2023 guidance on both 100%+ growth for 2023 and positive EBITDA in H2 2023 - supported by an already existing backlog. Redeye only expects to lower its 2023 estimates slightly. However, Redeye has revised its view on Ayar Labs and expects to raise its long-term estimates and its fair value range.